We are glad to show you the overview of Axcelead’s platform for molecular glue degrader discovery. Our high hit discovery success rate is attributed to our proprietary focused library and various HTS technologies. The discovery of lead compounds and candidates is strongly supported by various capabilities such as identifying the degradation mechanism of the obtained hits and comprehensive selectivity evaluation using proteomics and transcriptomics. In addition, our ability for searching novel neo-substrates is based on the combination of our proximity labeling and proteomics technology. Moreover, we also possess various capabilities subsequent validation. We have already collaborated with our partners to discover innovative drug discovery seeds in this area. We currently have dozens of proprietary molecular glue degrader candidates and neo-substrate candidates, which we plan to launch as new service in 2024. Please feel free to reach out to us to discover further information!